{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:55:33Z","timestamp":1790585733744,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00599-4","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:12:05Z","timestamp":1788343925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lynch syndrome\u2013associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3978-040X","authenticated-orcid":false,"given":"A.","family":"Rametta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Barbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tamborini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Busico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gusmaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Stellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Guadalupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Claps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. T.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pruneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Milione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giannatempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vitellaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"599_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","volume":"62","author":"HFA Vasen","year":"2013","unstructured":"Vasen HFA et al (2013) Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62:812\u2013823","journal-title":"Gut"},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10689-020-00193-2","volume":"20","author":"TT Sepp\u00e4l\u00e4","year":"2021","unstructured":"Sepp\u00e4l\u00e4 TT, Dominguez-Valentin M, Sampson JR, M\u00f8ller P (2021) Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD). Fam Cancer 20:35\u201339","journal-title":"Fam Cancer"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.euo.2021.11.001","volume":"5","author":"C Lonati","year":"2022","unstructured":"Lonati C et al (2022) Upper tract urothelial carcinoma in the Lynch syndrome tumour spectrum: a comprehensive overview from the European Association of Urology\u2014Young Academic Urologists and the Global Society of Rare Genitourinary Tumors. Eur Urol Oncol 5:30\u201341","journal-title":"Eur Urol Oncol"},{"key":"599_CR4","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","volume":"67","author":"P M\u00f8ller","year":"2018","unstructured":"M\u00f8ller P et al (2018) Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67:1306\u20131316","journal-title":"Gut"},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.1200\/JCO.2005.05.1771","volume":"24","author":"S Hern\u00e1ndez","year":"2006","unstructured":"Hern\u00e1ndez S et al (2006) Prospective study of FGFR3 mutations as a prognostic factor in non-muscle invasive urothelial bladder carcinomas. J Clin Oncol 24:3664\u20133671","journal-title":"J Clin Oncol"},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1053\/j.gastro.2023.04.027","volume":"165","author":"L Valle","year":"2023","unstructured":"Valle L (2023) Lynch syndrome: a single hereditary cancer syndrome or multiple syndromes defined by different mismatch repair genes? Gastroenterology 165:20\u201323","journal-title":"Gastroenterology"},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.juro.2010.12.102","volume":"185","author":"DG Crockett","year":"2011","unstructured":"Crockett DG, Wagner DG, Holm\u00e4ng S, Johansson SL, Lynch HT (2011) Upper urinary tract carcinoma in Lynch syndrome cases. J Urol 185:1627\u20131630","journal-title":"J Urol"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMoa2308849","volume":"389","author":"Y Loriot","year":"2023","unstructured":"Loriot Y et al (2023) Erdafitinib or chemotherapy in advanced or metastatic urothelial carcinoma. N Engl J Med 389:1961\u20131971","journal-title":"N Engl J Med"},{"key":"599_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.annonc.2023.09.3116","volume":"35","author":"JWF Catto","year":"2024","unstructured":"Catto JWF et al (2024) Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer. Ann Oncol 35:98\u2013106","journal-title":"Ann Oncol"},{"key":"599_CR10","first-page":"53","volume":"43","author":"R Li","year":"2025","unstructured":"Li R et al (2025) MOONRISE-1: Phase 3 study of TAR-210, an erdafitinib intravesical targeted releasing system, versus intravesical chemotherapy in patients with FGFR-altered intermediate-risk non\u2013muscle-invasive bladder cancer. Urol Oncol Semin Orig Investig 43:53","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"599_CR11","doi-asserted-by":"publisher","first-page":"116388","DOI":"10.1016\/j.celrep.2025.116388","volume":"44","author":"J Nikkola","year":"2025","unstructured":"Nikkola J et al (2025) Constrained hypermutation and absence of TERT promoter mutations in Lynch syndrome-associated urothelial cancer. Cell Rep 44:116388","journal-title":"Cell Rep"},{"key":"599_CR12","unstructured":"ClinGen Criteria Specification Registry - Available online: https:\/\/cspec.genome.network\/cspec\/ui\/svi\/"},{"key":"599_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.857515","author":"J Azzollini","year":"2022","unstructured":"Azzollini J et al (2022) Management of BRCA tumour testing in an integrated molecular tumour board multidisciplinary model. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.857515","journal-title":"Front Oncol"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1158\/0008-5472.CAN-17-0337","volume":"77","author":"JT Robinson","year":"2017","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Wenger AM, Zehir A, Mesirov JP (2017) Variant review with the Integrative Genomics Viewer. Cancer Res 77:e31\u2013e34","journal-title":"Cancer Res"},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/his.15091","volume":"84","author":"M Varma","year":"2024","unstructured":"Varma M, Comp\u00e9rat E, van der Kwast T (2024) Head\u2010to\u2010head: how many categories for grading urothelial carcinoma? Histopathology 84:421\u2013428","journal-title":"Histopathology"},{"key":"599_CR16","volume-title":"TNM classification of malignant tumours","year":"2025","unstructured":"Brierley JD, Giuliani M, O\u2019Sullivan B, Rous B, Van Eycken E (eds) (2025) TNM classification of malignant tumours. Wiley"},{"key":"599_CR17","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00143","author":"TF Donahue","year":"2018","unstructured":"Donahue TF et al (2018) Genomic characterization of upper-tract urothelial carcinoma in patients with lynch syndrome. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.17.00143","journal-title":"JCO Precis Oncol"},{"key":"599_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.euros.2026.02.010","volume":"86","author":"SM Monda","year":"2026","unstructured":"Monda SM et al (2026) Germline variants in bladder and upper tract urothelial cancers: prevalence and clinical context in a large testing registry. Eur Urol Open Sci 86:56\u201367","journal-title":"Eur Urol Open Sci"},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle A et al (2020) Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J Clin Oncol 38:1\u201310","journal-title":"J Clin Oncol"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","volume":"386","author":"A Cercek","year":"2022","unstructured":"Cercek A et al (2022) PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med 386:2363\u20132376","journal-title":"N Engl J Med"},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00432-025-06312-9","volume":"151","author":"P Duan","year":"2025","unstructured":"Duan P et al (2025) Deficient DNA mismatch repair and Nectin-4 expression in upper tract urothelial carcinoma (UTUC). J Cancer Res Clin Oncol 151:280","journal-title":"J Cancer Res Clin Oncol"},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12885-022-09259-z","volume":"22","author":"ML Calandrella","year":"2022","unstructured":"Calandrella ML et al (2022) Nectin-4 and DNA mismatch repair proteins expression in upper urinary tract urothelial carcinoma (UTUC) as a model for tumor targeting approaches: an ImGO pilot study. BMC Cancer 22:168","journal-title":"BMC Cancer"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00599-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:03:30Z","timestamp":1790582610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00599-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00599-4","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The funding informations have been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"85"}}